Adoptive Immunotherapy Against Ovarian Cancer

This review article was published by the Journal of Ovarian Research in May of 2016. Download the Publication The abstract: The standard front-line therapy for epithelial ovarian cancer (EOC) is combination of debulking surgery and platinum-based chemotherapy. Nevertheless, the majority of patients experience disease recurrence. Although extensive efforts to find … Continue reading Adoptive Immunotherapy Against Ovarian Cancer

Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer

This review article was published by the Trends in Immunology in May of 2016. Download the Publication The abstract: Many advances in the treatment of cancer have been driven by the development of targeted therapies that inhibit oncogenic signaling pathways and tumor-associated angiogenesis, as well as by the recent development … Continue reading Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer

Uterine Carcinosarcoma: A Review of the Literature

This review article was published by the Gynecologic Oncology in June of 2015. Download the Publication The abstract: Objective. Uterine carcinosarcomas (UCSs) are aggressive tumors previously considered to be sarcomas, but now recognized as malignancies composed of metaplastic transformation of epithelial elements. Much of the management for UCS has been … Continue reading Uterine Carcinosarcoma: A Review of the Literature

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine and Ovarian Carcinosarcoma

This review article was published by the International Journal of Gynecological Cancer in June of 2014. Download the Publication The abstract: Carcinosarcomas (also known as malignant mixed müllerian tumors) are rare and highly aggressive epithelial malignancies that contain both malignant sarcomatous and carcinomatous elements. Uterine carcinosarcomas (UCs) are uncommon with approximately … Continue reading Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine and Ovarian Carcinosarcoma

Carcinosarcoma of the Ovary: A Review of the Literature

This review article was published by Gynecologic Oncology in 2012. Download the Publication Highlights: Ovarian carcinosarcoma is a rare malignancy with a poor prognosis. Surgical debulking remains the mainstay of treatment. Platinum-based therapy is active in the treatment of ovarian carcinosarcoma. del Carmen MG, Birrer M, Schorge JO. Carcinosarcoma of … Continue reading Carcinosarcoma of the Ovary: A Review of the Literature

Uterine Sarcomas: A Review

This review article was published by Gynecologic Oncology in 2010. Download the Publication The abstract: Objective. Uterine sarcomas are rare tumors that account for 3% of uterine cancers. Their histopathologic classification was revised by the World Health Organization (WHO) in 2003. A new staging system has been recently designed by … Continue reading Uterine Sarcomas: A Review

Carcinosarcoma of the Ovary: A Review

This review article was published by Obstetrical and Gynecological Survey in 2009. Download the Publication Target Audience: Obstetricians & Gynecologists, Family Physicians Learning Objectives: After completion of this educational activity, the participant should be better able to recall the existence of carcinosarcoma of the ovary, demonstrate that with rare tumors, … Continue reading Carcinosarcoma of the Ovary: A Review

Current Management of Ovarian Carcinosarcoma

This review article was published by the International Journal of Gynecological Cancer in 2007. Download the Publication The abstract: Ovarian carcinosarcomas (OCS), also known as malignant mixed mu¨ llerian tumors, are uncommon malignancies that carry a poor prognosis. The presentation of OCS is usually indistinguishable from that of epithelial ovarian … Continue reading Current Management of Ovarian Carcinosarcoma